The project will have 200,000-sq.m. in residential, office and commercial spave.
Rosebud Medical Ltd. (TASE: ROSB) has acquired half of a 15.25-acre lot in downtown Bucharest for €72.9 million plus €2.6 million in costs. The lot is zoned for a 200,000-sq.m. residential, office and commercial project, which will take 5-6 years to build at a cost of €320 million.
Rosebud made the deal through a foreign subsidiary in which its owns a 50% stake.
Published by Globes [online], Israel business news - www.globes.co.il - on August 12, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007